Northwest Biotherapeutics Inc
OTC:NWBO

Watchlist Manager
Northwest Biotherapeutics Inc Logo
Northwest Biotherapeutics Inc
OTC:NWBO
Watchlist
Price: 0.285 USD -10.94% Market Closed
Market Cap: 435.7m USD

Wall Street
Price Targets

NWBO Price Targets Summary
Northwest Biotherapeutics Inc

There are no price targets for NWBO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Northwest Biotherapeutics Inc Competitors:
Price Targets
ABOS
Acumen Pharmaceuticals Inc
233% Upside
ARQT
Arcutis Biotherapeutics Inc
10% Upside
TRDA
Entrada Therapeutics Inc
67% Upside
4599
StemRIM Inc
164% Upside
4BB
4Basebio PLC
189% Upside
4974
Takara Bio Inc
39% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
25% Upside
SPRY
ARS Pharmaceuticals Inc
155% Upside

Revenue
Forecast

Revenue Estimate
Northwest Biotherapeutics Inc

For the last 13 years the compound annual growth rate for Northwest Biotherapeutics Inc's revenue is 46%. The projected CAGR for the next 11 years is 1%.

46%
Past Growth
1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Northwest Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Northwest Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NWBO's stock price target?
Not Available

NWBO doesn't have any price targets made by Wall Street professionals.

What is Northwest Biotherapeutics Inc's Revenue forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Northwest Biotherapeutics Inc's revenue is 46%. The projected CAGR for the next 11 years is 1%.

Back to Top